Ramsay Healthcare
(ASX:RHC) has reported its statutory NPAT is down 21 per cent to $388.3 million on last year’s figure $488.9 million.
In good news for the company, its revenue strengthened throughout the year up 5.4 per cent to $9.2 billion.
And its EBITDA is up 6.2 per cent to $1.4 billion.
Results were impacted by a downturn in NHS volumes in their UK business as well as softer growth rates in Australia business and the decision to temporarily slow down the rollout of the Ramsay Pharmacy franchise.
Final dividend is 86.5 cents fully franked, up 6.1 per cent on the previous corresponding period, bringing the full-year dividends to 144.0 cents fully franked, up 7.1 per cent.
Shares in Ramsay Healthcare
(ASX:RHC) closed 2.07 per cent higher to $58.16 yesterday.
